Survodutide 10mg – Glucagon/GLP-1 Receptor Dual Agonist Research Support
 
Survodutide (BI 456906) is a high-purity, synthetic peptide that acts as a potent dual agonist of both the glucagon receptor (GCGR) and the glucagon-like peptide-1 receptor (GLP-1R). It is synthesized for advanced laboratory research focusing on metabolic syndrome, non-alcoholic steatohepatitis (NASH/MASH), and the biochemical pathways of systemic energy expenditure.
Survodutide is extensively studied in experimental models for its unique "dual-action" mechanism. Unlike selective GLP-1 agonists, researchers investigate Survodutide for its ability to simultaneously activate the glucagon receptor—which increases energy expenditure and directly targets hepatic fat—and the GLP-1 receptor, which regulates glucose-dependent insulin secretion and suppresses appetite. In laboratory settings, it is researched for its capacity to improve mitochondrial function in the liver, modulate fibrotic signaling, and analyze the synergistic effects of multi-receptor activation on body composition. Its biochemical mechanism provides a primary subject for studies involving chronic weight management, glucose homeostasis, and the maintenance of systemic homeostasis during metabolic challenge.
This advanced research-grade peptide is frequently utilized in laboratory settings to analyze the interaction between incretin signaling and glucagon-mediated thermogenesis, as well as the maintenance of cellular resilience in metabolic research models.
High purity: 99% HPLC
CAS#: 2805997-46-8
Molecular Weight: 4231.6 g/mol
Chemical Formula: $C_{192}H_{289}N_{47}O_{61}$
 
For laboratory research use only. Not for human or veterinary consumption.
 
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.